Skip to main content
. 2020 Nov 20;10:20283. doi: 10.1038/s41598-020-77497-x

Figure 8.

Figure 8

Impact of DC-SIGN on tolerogenic properties and functions of ES L1-treated dendritic cells (DCs) challenged with pro-inflammatory stimulus. DCs treated with ES L1 products (50 μg/ml), in the presence or in the absence of specific DC-SIGN blocking antibodies (20 ng/ml), and then additionally activated or not with LPS, were washed thoroughly and then cocultured with magnetic-activated cell sorting-purified allogenic T cells (Tly) in 1:50 DC:T cell ratio, as described. (A) Representative analysis of CD25+FoxP3+ cells within CD4+ T cells from one experiment is shown, (B) Representative analysis of IL-10 and transforming growth factor (TGF)-β within CD4+CD25+ T cell population is shown, and (C) the summarized results for the expression of CD4+CD25+FoxP3+ T regulatory cells and IL-10 and TGF-β within CD4+CD25+ T cells are shown as the mean% ± SD from three different experiments. *p < 0.05, **p < 0.01, ***p < 0.005 compared as indicated (one-way ANOVA with Tukey’s posttest).